There are risks associated with injectable GHK-Cu
The US FDA approved macimorelin in December 2017, with a GH cut-off of 2.8 g/L for diagnosing GHD
doi: 10.3389/fendo.2024.1401120 Received 14 March 2024 Accepted 10 June 2024 Published 08 July 2024 Volume 15 - 2024 Edited by Anna-Maria Andersson, Department of Growth and Reproduction, Rigshospitalet, Denmark Reviewed by Chad Deisenroth, United States Environmental Protection Agency (EPA), United States Ella Atlas, Health Canada, Canada Updates Copyright 2024 Ozcagli, Kubickova and Jacobs
Summary: Rybelsus (semaglutide) takes approximately four to five weeks to be substantially eliminated from the body after the last dose
Link Here 3
Always consult your healthcare provider, especially if you're on medication or have specific health conditions